Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

S H Chen, H D Shine, J C Goodman, R G Grossman, S L Woo, S H Chen, H D Shine, J C Goodman, R G Grossman, S L Woo

Abstract

The therapeutic efficacy of adenovirus-mediated herpes simplex virus thymidine kinase (HSV-tk) gene transduction of rat C6 glioma cells followed by ganciclovir (GCV) administration was studied in tumors generated in the brains of nude mice. C6 glioma cells were efficiently transduced in vitro by a replicative-defective recombinant adenovirus carrying the HSV-tk gene (ADV/RSV-tk) that rendered them sensitive to GCV in a dose-dependent manner. Tumors were generated by stereotaxic intracerebral injection of 1 x 10(4) C6 cells in nude mice. After 8 days of tumor growth, 3 x 10(8) ADV/RSV-tk viral particles were injected into the tumors and the mice subsequently were treated with GCV for 6 days. Tumor size in untreated and treated animals was compared 20 days after tumor implantation. The mean cross-sectional area of the tumors in the treated animals was 23-fold smaller than in control animals and the tumor volume was reduced by > 500-fold. These results demonstrate that the recombinant adenoviral vector can function as an efficient gene delivery vehicle for the treatment of gliomas by in vivo gene therapy.

References

    1. Science. 1968 Jul 26;161(3839):370-1
    1. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7024-8
    1. Cancer Res. 1986 Oct;46(10):5276-81
    1. J Natl Cancer Inst. 1990 Feb 21;82(4):297-300
    1. Hum Gene Ther. 1990 Summer;1(2):125-34
    1. Hum Gene Ther. 1990 Fall;1(3):241-56
    1. Neurosci Lett. 1991 May 13;126(1):33-6
    1. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8039-43
    1. New Biol. 1991 Jun;3(6):608-14
    1. New Biol. 1991 Jul;3(7):709-15
    1. Cell. 1992 Jan 10;68(1):143-55
    1. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2581-4
    1. Science. 1992 Jun 12;256(5063):1550-2
    1. Cancer Res. 1992 Aug 1;52(15):4208-13
    1. J Clin Invest. 1992 Aug;90(2):626-30
    1. Cancer Res. 1993 Jan 1;53(1):83-8
    1. J Neurosci Res. 1992 Nov;33(3):493-503
    1. Science. 1993 Feb 12;259(5097):988-90
    1. Hum Gene Ther. 1993 Feb;4(1):39-69
    1. Nat Genet. 1993 Mar;3(3):219-23
    1. Nat Genet. 1993 Mar;3(3):224-8
    1. Nat Genet. 1993 Mar;3(3):229-34
    1. Nat Genet. 1993 May;4(1):27-34
    1. J Biol Chem. 1978 Dec 25;253(24):8721-7

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir